1. Pink Sheet

Califf Suggests Congress ‘Tighten Up Laws’ To Address Orange Book Abuses

 
• By Sarah Karlin-Smith

US FDA Commissioner repeats longstanding FDA policy that the agency doesn’t have much power to address frivolous patent listings in the Orange Book, but seems to support Congress providing more authority.

FDA Commissioner Robert Califf
FDA Commissioner Robert Califf testified at the House Oversight Committee on 11 April. • Source: Screenshot

To take more aggressive action against patent tactics used to thwart generic competition, Congress should work with the US Food and Drug Administration and Patent and Trademark Office to craft legislation, FDA Commissioner Robert Califf said.

While testifying at the House Oversight Committee on 11 April, Califf was pressed by Rep. Ro Khanna, D-CA, on why...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

New EFPIA President Hopes ‘Sanity Will Prevail’ In EU Pharma Reform Dialogs

 
• By Eliza Slawther

Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.

UK Pilots Faster Setup Of Early Phase Oncology Trials

 
• By Vibha Sharma

Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.

US CDC Vaccine Committee Revives Thimerosal Debate: A Portent Of Things To Come?

 
• By Bridget Silverman

The new Advisory Committee on Immunization Practices voted for new recommendations on the decades-old thimerosal safety issue and lays intellectual groundwork to revisit other past controversies and decisions.